Interaction of non-coding RNAs and Hippo signaling: Implications for tumorigenesis

Can Liu1, Yangge Wu1, Jian Ma1

  • 1Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China; Cancer Research Institute, School of Basic Medical Science, NHC Key Laboratory of Carcinogenesis, Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Central South University, Changsha, China; Hunan Key Laboratory of Nonresolving Inflammation and Cancer, The Third Xiangya Hospital, Central South University, Changsha, China.

Cancer Letters
|August 22, 2020
PubMed

Insights

The Hippo signaling pathway regulates organ size and is crucial in cancer. Its interaction with non-coding RNAs (ncRNAs) offers potential cancer biomarkers and therapeutic targets.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Genetics

Background:

  • The Hippo signaling pathway is a conserved regulator of organ size, controlling cell proliferation, apoptosis, and stem cell renewal.
  • Aberrant Hippo pathway activity is implicated in the development and metastasis of various cancers.
  • Non-coding RNAs (ncRNAs), including microRNAs, long non-coding RNAs, and circular RNAs, are increasingly recognized for their roles in tumorigenesis.

Purpose of the Study:

  • To review the intricate interactions between the Hippo signaling pathway and ncRNAs.
  • To elucidate the implications of these interactions in cancer development and progression.
  • To explore the potential of these interactions as cancer biomarkers and therapeutic targets.

Main Methods:

  • Literature review of studies investigating Hippo pathway and ncRNA crosstalk.
  • Analysis of research on the functional roles of ncRNAs in Hippo pathway-mediated tumorigenesis.
  • Synthesis of evidence regarding clinical applications of Hippo pathway-ncRNA interactions.

Main Results:

  • The Hippo pathway and ncRNAs exhibit complex regulatory crosstalk influencing cancer.
  • Specific ncRNAs can act as tumor suppressors or oncogenes by modulating Hippo pathway components.
  • These interactions contribute to diverse tumor-promoting or tumor-repressing effects.

Conclusions:

  • The interplay between the Hippo pathway and ncRNAs is a critical factor in tumorigenesis.
  • Understanding these interactions provides novel insights into cancer mechanisms.
  • Hippo pathway-ncRNA networks represent promising avenues for developing cancer biomarkers and therapeutic strategies.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
9.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K